Skip to content
Review

Electrochemical biosensing of non-coding RNAs for prostate Cancer diagnosis and prognosis.

Aug 2026 · Clinica chimica acta; international journal of clinical chemistry · Vol 593, pp. 121297 · 0 citations · 95 references
Medicine

TL;DR

The present review focuses on the significance of ncRNAs as diagnostic markers for PCa and summarizes recent progress in biosensing technologies, emphasizing electrochemical methods designed to identify ncRNAs associated with this cancer.

Abstract

Prostate cancer (PCa) is a prevalent malignancy with high mortality, partly due to the lack of reliable diagnostic methods. In recent years, non-coding RNAs (ncRNAs) have gained recognition as promising indicators for accurate disease detection and outcome prediction, given their inherent stability and expression profiles that are specific to pathological states. To enable the measurement of these biomolecules, a range of biosensors especially electrochemical sensing systems have been developed, providing advantages such as high precision in diagnosis, fast response times, and low cost. The present review focuses on the significance of ncRNAs as diagnostic markers for PCa and summarizes recent progress in biosensing technologies, emphasizing electrochemical methods designed to identify ncRNAs associated with this cancer.

View source

Similar papers

Open access

Optical and Electrochemical Detection of Prostate Cancer Biomarker PCA3 Using Specific Aptasensor

Prostate cancer (PCa) is one of the most prevalent malignancies among men worldwide. Although prostate-specific antigen (PSA) testing has improved early detection of PCa, its limited specificity leads to false positives and false negatives, resulting in overdiagnosis and unnecessary biopsies. These limitations highligh...

S. Takita · 0 citations
Oct 2026

An electroactive RNA-cleaving DNAzyme based electrochemical biosensor for enzyme-free detection of microRNA.

Cancer remains among the leading causes of mortality globally, where the detection of biomarkers is essential for early diagnosis and accurate prognosis. Among them, microRNA-21 (miR-21) is a clinically significant oncogenic biomarker that is dysregulated across various cancers, highlighting the need for rapid, sensiti...

Gopi Karuppaiah, Aneesh Koyappayil, S. Chavan et al. · 0 citations
Review Oct 2026

Optical biosensors for cancer diagnosis and monitoring.

This review critically presents the fundamental principles, sensor configurations, and applications of optical biosensors for cancer detection and monitoring, with particular emphasis on technological advances that underpin sensitivity, specificity, multiplexing, and clinical translation.

H. Saputra, Md Ali Zaber Sahin, Y. Hartati · 0 citations
Review Sep 2026

Electrochemical Biosensors for Circulating Tumor Cells and ctDNA: Emerging Strategies for Precision Oncology.

This work highlights strategies specifically designed for epithelial-mesenchymal transition (EMT)-associated CTC phenotypes and explores AI- and IoT-enabled implementations for decentralized oncology, and a comprehensive evaluation of electrochemical approaches for CTC and ctDNA detection.

Tuğba Ören Varol, Mehmet Varol · 0 citations
Dec 2026

Flavin mononucleotide-based biomimetic redox flow biosensor for rapid miRNA-21 detection in colorectal cancer diagnostics.

Detection of tumor biomarkers in serum and cellular samples is essential for early diagnosis and precision treatment of colorectal cancer, and miRNA-21 is well-established as a pivotal oncogenic biomarker for this malignancy. Conventional nucleic acid detection methods typically rely on complex enzymatic amplification...

Nan Ma, Yue-Lan Fang, Xiao-Ran Wu et al. · 0 citations
Review Open access Oct 2026

Advances in Urinary Liquid Biopsy: A Review of Emerging Sensing Platforms for Early Cancer Screening and Diagnosis

Early screening of many types of cancers remains limited by the invasiveness of gold-standard tissue biopsies and the poor specificity of traditional clinical biomarkers like prostate-specific antigen (PSA). Non-invasive liquid biopsies are the emerging alternatives. Urine is one of the preferred body fluids for liquid...

Eleni Lamprou, Dimitrios Papakyriakou, D. Kalogianni · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.